NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Clinical trial NCT05352646 · UNKNOWN
Trial details
- NCT number
- NCT05352646
- Sponsor
- Newish Technology (Beijing) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2024-06-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.